Moderate

Hereditary spherocytosis (HS; congenital spherocytic haemolytic anaemia)

Haemolytic anaemia · Haematology / Oncology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Inherited red-cell membrane defect (ankyrin/spectrin/band 3) -> spherocytes removed by spleen -> chronic haemolysis, jaundice, splenomegaly, gallstones. Often known from childhood. ED presentations: haemolytic crisis (infection-triggered), aplastic crisis (parvovirus B19), or gallstone complications.

Red flags

  • Aplastic crisis: rapidly falling Hb with LOW reticulocytes (parvovirus B19)
  • Severe symptomatic anaemia (cardiac compromise)
  • Overwhelming post-splenectomy sepsis (asplenic, encapsulated organisms)
  • Acute cholecystitis / biliary obstruction from pigment stones
  • Megaloblastic crisis from folate depletion

Assessment

Differential diagnosis

  • Warm autoimmune haemolytic anaemia (spherocytes too - but DAT positive)
  • G6PD deficiency / other enzymopathy
  • Other membranopathies (elliptocytosis)
  • Neonatal jaundice causes
  • Haemolysis from sepsis/DIC

Investigations

  • FBC + reticulocytes (raised) + blood film (spherocytes, polychromasia)
  • DAT/Coombs - NEGATIVE (distinguishes from autoimmune haemolysis with spherocytes)
  • Haemolysis screen: bilirubin (unconjugated) up, LDH up, haptoglobin down
  • Raised MCHC is a classic clue; EMA binding test or osmotic fragility / flow cytometry confirms
  • Parvovirus B19 serology/PCR if aplastic crisis (low reticulocytes with anaemia)
  • USS for gallstones; family history

Management

  • Confirm chronic HS vs new autoimmune haemolysis (DAT negative in HS)
  • Haemolytic crisis (usually infection-triggered): supportive care, treat trigger, transfuse if symptomatic/severe
  • Aplastic crisis (parvovirus B19): reticulocytopenia + falling Hb - transfuse as needed, usually self-limiting over ~1-2 weeks, isolate from pregnant staff/patients
  • Folic acid supplementation for chronic haemolysis
  • Manage gallstone complications (biliary colic, cholecystitis, pigment stones) on standard pathway
  • Splenectomy reserved for severe/transfusion-dependent cases - ensure vaccination (pneumococcal, meningococcal, Hib) + penicillin prophylaxis
  • Monitor for megaloblastic change if folate deficient

Drugs & doses

Folic acid 5 mg PO once daily (chronic/ongoing haemolysis)
Transfuse packed red cells for symptomatic/severe anaemia or aplastic crisis (DAT negative - standard cross-match straightforward) [verify local dose]
Pre-splenectomy vaccination: pneumococcal, meningococcal ACWY + B, Hib; lifelong penicillin V 250-500 mg PO twice daily post-splenectomy [verify local dose]
Antibiotics for infective trigger as indicated

Disposition

Significant crisis (haemolytic/aplastic) or symptomatic anaemia -> admit with haematology. Mild/known case with trigger -> treat and discharge with follow-up and folic acid.

Complications & pitfalls

  • Pigment gallstones / cholecystitis
  • Aplastic crisis (parvovirus B19)
  • Megaloblastic crisis (folate deficiency)
  • Post-splenectomy sepsis and thrombosis
  • Leg ulcers, iron overload if frequently transfused

Exam pearls

  • Spherocytes + NEGATIVE DAT + raised MCHC = hereditary spherocytosis; spherocytes + POSITIVE DAT = autoimmune haemolysis
  • A sudden drop with low reticulocytes in a known HS patient = parvovirus B19 aplastic crisis, not worsening haemolysis
  • Lifelong folic acid prevents megaloblastic crises
  • Post-splenectomy patients need vaccination, penicillin prophylaxis and a low threshold for treating fever as sepsis
  • Gallstones are common and young - have a low threshold for biliary imaging

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.